Detailed Explanation
The CIOMS form provides an internationally accepted format for expedited reporting of individual case safety reports from clinical trials, ensuring that essential information about suspected adverse drug reactions is communicated consistently and comprehensively to regulatory authorities. Developed collaboratively by CIOMS and the World Health Organization, this standardized template has been adopted by regulatory agencies worldwide and forms the basis for electronic safety reporting formats such as the ICH E2B specification.
The CIOMS I form captures key information in a structured, single-page format designed for rapid review. Fields include patient demographics and relevant medical history, details of the suspected drug including dosage and dates of administration, information about concomitant medications, a description of the adverse reaction including onset date, duration, and outcome, relevant laboratory data, the reporter's assessment of causality, and any actions taken such as drug withdrawal or rechallenge. This comprehensive but concise format enables regulatory reviewers to quickly assess the significance of individual reports.